The effect of the cleidocranial dysplasia-related novel 1116_1119insC mutation in the RUNX2 gene on the biological function of mesenchymal cells

European Journal of Medical Genetics

Volumn 56, Issue 4, 2013, Pages 180-187

  Ding, Bofu ^a,b   Li, Chanjuan ^a   Xuan, Kun ^a   Liu, Na ^a   Tang, Liang ^a   Liu, Yali ^a   Guo, Weihua ^a   Liu, Weihong ^b,c   Jin, Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c not available ^*  (China)

Author keywords

Cleidocranial dysplasia; Mesenchymal stem cells; Mutation; RUNX2

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR RUNX2;

ADULT; ARTICLE; BIOLOGICAL FUNCTIONS; BONE DEVELOPMENT; BONE MARROW CELL; CASE REPORT; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CLEIDOCRANIAL DYSPLASIA; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; MALE; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; ODONTOBLAST; OSSIFICATION; OSTEOBLAST; PROTEIN ISOLATION; TOOTH DEVELOPMENT; TOOTH PULP; WNT SIGNALING PATHWAY;

EID: 84875883631     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2013.01.009     Document Type: Article

References (28)

1. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999, 13(8):1025-1036.
2. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19(3):180-192.
3. Gronthos S., Brahim J., Li W., Fisher L.W., Cherman N., Boyde A., DenBesten P., Robey P.G., Shi S. Stem cell properties of human dental pulp stem cells. J. Dent Res. 2002, 81(8):531-535.
4. Quack I., Vonderstrass B., Stock M., Aylsworth A.S., Becker A., Brueton L., Lee P.J., Majewski F., Mulliken J.B., Suri M., Zenker M., Mundlos S., et al. Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am. J. Hum. Genet. 1999, 65(5):1268-1278.
5. Xuan D., Sun X., Yan Y., Xie B., Xu P., Zhang J. Effect of cleidocranial dysplasia-related novel mutation of RUNX2 on characteristics of dental pulp cells and tooth development. J. Cell. Biochem. 2010, 111(6):1473-1481.
6. Ziros P.G., Basdra E.K., Papavassiliou A.G. Runx2: of bone and stretch. Int. J. Biochem. Cell. Biol. 2008, 40(9):1659-1663.
7. Kundu M., Javed A., Jeon J.P., Horner A., Shum L., Eckhaus M., Muenke M., Lian J.B., Yang Y., Nuckolls G.H., Stein G.S., Liu P.P. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat. Genet. 2002, 32(4):639-644.
8. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997, 89(5):755-764.
9. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434(7035):843-850.
10. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell. 2005, 8(5):739-750.
11. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell. 2005, 8(5):727-738.
12. Tang L., Li N., Xie H., Jin Y. Characterization of mesenchymal stem cells from human normal and hyperplastic gingiva. J. Cell. Physiol. 2010, 226(3):832-842.
13. Huo N., Tang L., Yang Z., Qian H., Wang Y., Han C., Gu Z., Duan Y., Jin Y. Differentiation of dermal multipotent cells into odontogenic lineage induced by embryonic and neonatal tooth germ cell-conditioned medium. Stem Cells Dev. 2010, 19(1):93-104.
14. Liu G., Vijayakumar S., Grumolato L., Arroyave R., Qiao H., Akiri G., Aaronson S.A. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J. Cell. Biol. 2009, 185(1):67-75.
15. Zaidi S.K., Javed A., Choi J.Y., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell. Sci. 2001, 114(Pt 17):3093-3102.
16. Tang L., Guo B., Javed A., Choi J.Y., Hiebert S., Lian J.B., van Wijnen A.J., Stein J.L., Stein G.S., Zhou G.W. Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2. J. Biol. Chem. 1999, 274(47):33580-33586.
17. Harrington K.S., Javed A., Drissi H., McNeil S., Lian J.B., Stein J.L., Van Wijnen A.J., Wang Y.L., Stein G.S. Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains. J. Cell. Sci. 2002, 115(Pt 21):4167-4176.
18. Choi J.Y., Pratap J., Javed A., Zaidi S.K., Xing L., Balint E., Dalamangas S., Boyce B., van Wijnen A.J., Lian J.B., Stein J.L., Jones S.N., et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(15):8650-8655.
19. Afzal F., Pratap J., Ito K., Ito Y., Stein J.L., van Wijnen A.J., Stein G.S., Lian J.B., Javed A. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J. Cell. Physiol. 2005, 204(1):63-72.
20. Westendorf J.J., Zaidi S.K., Cascino J.E., Kahler R., van Wijnen A.J., Lian J.B., Yoshida M., Stein G.S., Li X. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell. Biol. 2002, 22(22):7982-7992.
21. San Martin I.A., Varela N., Gaete M., Villegas K., Osorio M., Tapia J.C., Antonelli M., Mancilla E.E., Pereira B.P., Nathan S.S., Lian J.B., Stein J.L., et al. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells. J. Cell. Physiol. 2009, 221(3):560-571.
22. Drissi H., Luc Q., Shakoori R., Chuva De Sousa Lopes S., Choi J.Y., Terry A., Hu M., Jones S., Neil J.C., Lian J.B., Stein J.L., Van Wijnen A.J., et al. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J. Cell. Physiol. 2000, 184(3):341-350.
23. Schroeder T.M., Jensen E.D., Westendorf J.J. Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res. C Embryo Today 2005, 75(3):213-225.
24. Maruyama Z., Yoshida C.A., Furuichi T., Amizuka N., Ito M., Fukuyama R., Miyazaki T., Kitaura H., Nakamura K., Fujita T., Kanatani N., Moriishi T., et al. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev. Dyn. 2007, 236(7):1876-1890.
25. Quarto N., Behr B., Longaker M.T. Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering. Tissue Eng. Part. A 2010, 16(10):3185-3197.
26. Javed A., Bae J.S., Afzal F., Gutierrez S., Pratap J., Zaidi S.K., Lou Y., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J. Biol. Chem. 2008, 283(13):8412-8422.
27. Ducy P. Cbfa1: a molecular switch in osteoblast biology. Dev. Dyn. 2000, 219(4):461-471.
28. Kim H.J., Nam S.H., Park H.S., Ryoo H.M., Kim S.Y., Cho T.J., Kim S.G., Bae S.C., Kim I.S., Stein J.L., van Wijnen A.J., Stein G.S., et al. Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J. Cell. Physiol. 2006, 207(1):114-122.